Showing results (31-40 of 516) with videos related to

Sort By:
Pageof 52
Gastroenterology Clinics of North America|October 30, 2020
Nonbiologic Immune Suppression in Ulcerative ColitisValérie Heron, Edward V Loftus
The Medical Clinics of North America|December 1, 2009
Safety profile of IBD therapeutics: infectious risksWaqqas Afif, Edward V Loftus
Inflammatory Bowel Diseases|June 6, 2023
Characteristics, Clinical Outcomes, and Prognosis of Anal and Pouch-related Carcinoma in Patients With Crohn's DiseaseTanita Suttichaimongkol, Edward V Loftus
Drug Design, Development and Therapy|December 14, 2016
Ustekinumab in treatment of Crohn's disease: design, development, and potential place in therapyParakkal Deepak, Edward V Loftus
The Journal of Investigative Dermatology|May 7, 2023
Adalimumab Therapeutic Drug Monitoring Improves Treatment Outcome in Patients with PsoriasisAfsaneh Alavi, Edward V Loftus
Current Treatment Options in Gastroenterology|December 31, 2004
Medical Therapy of Crohn's DiseaseShamina Dhillon, Edward V Loftus
Gastroenterology Clinics of North America|November 17, 2009
Safety profile of IBD therapeutics: infectious risksWaqqas Afif, Edward V Loftus
Gastroenterology & Hepatology|February 21, 2012
Mucosal healing in inflammatory bowel disease-a true paradigm of success?Maneesh Dave, Edward V Loftus
Gastroenterology Clinics of North America|June 5, 2004
Management of refractory inflammatory bowel diseaseCraig A Solem, Edward V Loftus
The American Journal of Gastroenterology|September 27, 2005
Avoiding the vicious cycle of prolonged opioid use in Crohn's diseaseJennifer L Jones, Edward V Loftus
Pageof 52